首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Comparative evaluation of supplemented peptone broth with sodium polyanetholesulfonate and trypticase soy broth with sodium amylosulfate for detection of septicemia.
【2h】

Comparative evaluation of supplemented peptone broth with sodium polyanetholesulfonate and trypticase soy broth with sodium amylosulfate for detection of septicemia.

机译:聚腺苷磺酸钠补充蛋白ept肉汤和淀粉淀粉硫酸钠对胰蛋白酶酶大豆肉汤检测败血病的比较评价。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

We compared the yield and speed of detection of clinically important microorganisms from 10,156 paired 5-ml samples of blood cultured in supplemented peptone broth (SPB) with 0.03% sodium polyanetholesulfonate (SPS) or Trypticase soy broth (TSB) with 0.5% sodium amylosulfate (SAS). The atmosphere of incubation (open venting units) and ratio of blood to broth (1:10) were the same for both samples. Only cultures with adequate blood samples (greater than or equal to 80% of stated volume) were compared statistically. Overall, SPB/SPS outperformed TSB/SAS. Bacteroidaceae and Eubacterium were found more often (P less than 0.05) and viridans streptococci were found sooner (P less than 10(-4)) in SPB/SPS than in TSB/SAS. Most importantly, staphylococci were found both more often (P less than 0.03) and sooner (P less than 10(-7)) in SPB/SPS than in TSB/SAS. In a separate experiment, SAS slowed the growth of a clinical strain of Staphylococcus aureus in TSB. Unless important advantages can be confirmed for SAS in controlled clinical trials, SAS cannot be recommended for routine use as an anticoagulant in blood culture media.
机译:我们比较了从10,156对配对的5 ml血液样本中检测到的重要临床微生物的产率和检测速度,这些样本在添加有0.03%聚蒽硫磺酸钠(SPS)的胰蛋白bro肉汤(SPB)或带有0.5%淀粉状磺化硫酸钠的胰蛋白酶大豆肉汤(TSB)中进行了检测( SAS)。两种样品的孵育气氛(通风单元)和血与肉汤的比例(1:10)相同。仅对具有足够血样(大于或等于所述体积的80%)的培养物进行统计比较。总体而言,SPB / SPS优于TSB / SAS。与TSB / SAS中相比,SPB / SPS中发现细菌类杆菌和真细菌的频率更高(P小于0.05),并且发现了绿藻链球菌(P小于10(-4))。最重要的是,与TSB / SAS中相比,SPB / SPS中发现葡萄球菌的频率更高(P小于0.03),并且更早(P小于10(-7))。在另一项实验中,SAS减缓了TSB中金黄色葡萄球菌临床菌株的生长。除非可以在对照临床试验中确认SAS具有重要的优势,否则不建议将SAS作为血液培养基中的抗凝剂常规使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号